Table 2 Patient demographics and clinical characteristics of bone DLBCL
Parameter | uPB-DLBCL | mPB-DLBCL | SB-DLBCL |
|---|---|---|---|
Total | 37 | 23 | 23 |
Age range, years | 15-89 | 17-82 | 29-82 |
Median age, years | 53.0 | 60.0 | 54.0 |
Mean age, years | 52.9 | 53.4 | 55.0 |
<60, n (%) | 22(59.5) | 11(47.8) | 15(65.2) |
ā„60, n (%) | 15(40.5) | 12(52.2) | 8(34.8) |
Sex | Ā | Ā | Ā |
Male, n (%) | 22(59.5) | 14(60.9) | 9(39.1) |
Female, n (%) | 15(40.5) | 9(39.1) | 14(60.9) |
Male :female ratio | 1.5:1 | 1.6:1 | 0.6:1 |
Race | Ā | Ā | Ā |
White, n (%) | 33(89.2) | 21(91.3) | 17(73.9) |
Black, n (%) | 2(5.4) | 1(4.3) | 3(13.0) |
Unknown, n (%) | 2(5.4) | 1(4.3) | 3(13.0) |
B symptoms, n (%) | 7(18.9) | 8(34.8) | 8(34.8) |
LDH | Ā | Ā | Ā |
Normal | 23(79.3) | 5(29.4) | 8(57.1) |
Elevated | 6(20.7) | 12(70.6) | 6(42.9) |
Lymph node involvement, n (%) | 4(10.8)* | 9(39.1)* | 14(60.9)** |
Bone marrow involvement, n (%) | 3(8.1) | 5(21.7) | 7(30.4) |
Number of bone sites, n (%) | Ā | Ā | Ā |
Unifocal | 37(100.0) | 0(0) | 7(30.4) |
Multifocal | 0(0) | 23(100.0) | 16(69.6) |
Sites, n (%) | Ā | Ā | Ā |
Appendicular | 29(78.4) | 10(43.5) | 7(30.4) |
Axial | 8(21.6) | 2(8.7) | 9(39.1) |
Both | 0(0) | 11(47.8) | 7(30.4) |
Stage, n (%) | Ā | Ā | Ā |
IE | 30(81.1) | 0(0) | 1(4.3) |
IIE | 4(10.8) | 0(0) | 2(8.7) |
IIIE | 0(0) | 0(0) | 0(0) |
IVE | 3(8.1) | 23(100.0) | 20(87.0) |